Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

158
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
158
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

183
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
183

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic and functional insights into Alcaligenes pakistanensis subsp. lycopodii subsp. nov. -deciphering crosstalk with Lycopodium clavatum L. for bioinoculant potential.

Folia microbiologica·2026
Same author

Correction to "Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity".

ACS applied bio materials·2026
Same author

Phosphodiesterase 5 Inhibitor Sildenafil Inhibits HPV<sup>+</sup> Cervical Cancer Cells and Cervical Cancer Stem Cells by Apoptotic Induction and Telomerase Activity Modulation.

Anticancer research·2026
Same author

Lewis Acid Catalyzed Dual Strain-Release Platform for Transforming Azabicyclo[1.1.0]butanes into Functionalized Azetidines with Donor-Acceptor(D-A) Cyclopropanes and Bicyclo[1.1.0]butanes.

Organic letters·2026
Same author

Fecal microbiota transplantation in liver diseases: Therapeutic potential and associated risks.

Progress in molecular biology and translational science·2026
Same author

Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio-Receptors.

Chemistry, an Asian journal·2026
Same journal

Click-Chemistry-Based Antibacterial Hybrid Hydrogel with Sustained Puerarin Release for Diabetic Wound Healing.

ACS applied bio materials·2026
Same journal

Nanotechnology in Plastic and Reconstructive Surgery: Emerging Innovations in Wound Healing, Aesthetic Applications, and Skin Regeneration.

ACS applied bio materials·2026
Same journal

Therapeutic Vaccines Based on Iron-Coordinated Metal-Phenolic Networks for Eradicating Drug-Resistant Staphylococcus aureus.

ACS applied bio materials·2026
Same journal

Resveratrol-Engineered Modified Chitosan-PVP-AgNP Composite Hydrogel Patch: A Potential Antibacterial and Antioxidant Biomaterial for Infected Wound Healing.

ACS applied bio materials·2026
Same journal

Multiresponsive <b>β</b>-Cyclodextrin-Modified Hyaluronic Acid Hydrogel Loaded with Cu-Zn Nanozymes for Accelerated Diabetic Wound Healing.

ACS applied bio materials·2026
Same journal

Heterogeneous "Battery-Bulb" Coupling: Energy Transfer Mechanism from ZnGa<sub>2</sub>O<sub>4</sub>:Mn<sup>2+</sup> → La<sub>2</sub>MgTiO<sub>6</sub>:Er<sup>3+</sup> and NIR-IIb Afterglow Imaging.

ACS applied bio materials·2026
See all related articles

Related Experiment Video

Updated: Jul 7, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K

Vesicle-Encapsulated Rolipram (PDE4 Inhibitor) and Its Anticancer Activity.

Durga Mondal1, Arka Bagchi2, Sima Biswas3

  • 1Department of Chemistry, University of Kalyani, Kalyani, West Bengal 741235, India.

ACS Applied Bio Materials
|December 27, 2023
PubMed
Summary
This summary is machine-generated.

Niosomes demonstrated superior drug delivery compared to bilosomes for Rolipram, a breast cancer therapeutic. This enhanced delivery significantly reduced the drug

Keywords:
MCF-7 cell linePDE4 inhibitorRoliprambilosomescytotoxicitydrug deliveryniosomesvesicles

More Related Videos

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

11.6K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

Related Experiment Videos

Last Updated: Jul 7, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.0K
An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

11.6K
Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

13.2K

Area of Science:

  • Nanotechnology and Pharmaceutical Sciences
  • Drug Delivery Systems
  • Biomedical Engineering

Background:

  • Liposomes are common drug carriers but have limitations.
  • Niosomes and bilosomes offer enhanced stability and targeted delivery.
  • Bilosomes are particularly suited for gastrointestinal tract delivery due to their stability.

Purpose of the Study:

  • To prepare and characterize niosomes and bilosomes for drug delivery.
  • To evaluate the efficiency of these vesicles in delivering Rolipram, an anti-breast cancer drug.
  • To investigate the potential of taurine-derived bile salt (NaTC) in bilosome formulation.

Main Methods:

  • Preparation and characterization of niosomes and bilosomes.
  • Study of vesicle environment using fluorescence probing.
  • Assessment of Rolipram entrapment, release, and efficacy on MCF-7 breast cancer cells.

Main Results:

  • Niosomes showed significantly better performance than bilosomes in the MCF-7 breast cancer cell line.
  • Rolipram encapsulated in niosomes exhibited a 4-fold decrease in IC50 compared to Rolipram alone.
  • Bilosome-encapsulated Rolipram showed a higher IC50, indicating lower efficacy in this context.

Conclusions:

  • Niosomes are a promising drug delivery system for Rolipram in breast cancer therapy.
  • Bilosomes, while stable, were less effective than niosomes for this specific application.
  • Further studies, including molecular docking, are warranted to understand these delivery dynamics.